Company profile: ProBioGen
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing and technology services for biopharmaceuticals, specializing in cell line engineering, scalable upstream and downstream process development, GMP manufacturing, and virus production. Offers development and manufacturing of therapeutic proteins and antibodies, custom stable production cell lines, and support for biosimilars and biobetters.
Products and services
- GMP Manufacturing: Delivers GMP-compliant, consistent biopharmaceutical production integrating upstream- and downstream-process operations in mammalian cell culture, enabling reproducible fabrication of antibodies, therapeutic enzymes, and viruses to specification
- Process Development: Architects scalable upstream- and downstream-process development from milligrams to kilograms for biopharmaceutical production, optimizing mammalian cell culture parameters and yields to seamlessly bridge laboratory work to manufacturing
- Cell Lines: Engineers custom-engineered, stable mammalian production cell lines tailored to specific molecules, enabling robust expression platforms for antibodies, therapeutic proteins, and viruses based on long-term culture expertise
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ProBioGen
Endeavor Clinical Trials
HQ: United States
Website
- Description: Provider of research and clinical trials specializing in surgical, orthopedic, and specialty medicine, based in San Antonio, Texas, with over 20 years of experience; one of 8 portfolio research units.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endeavor Clinical Trials company profile →
Aenova
HQ: United States
Website
- Description: Provider of pharmaceutical and healthcare services, including development, manufacturing and packaging of pharmaceuticals and dietary supplements across oral solids, semi-solids, liquids, sterile dosage forms, and soft gelatin and vegan soft capsules. Offers formulation, process and analytical development, stability studies, regulatory support, clinical trial management, animal health services, and biologics fill and finish for vials and prefilled syringes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aenova company profile →
Regulatory Professionals
HQ: United States
Website
- Description: Provider of regulatory expertise and end-to-end development support to biotechnology, pharmaceutical and medical device companies, including strategic product development, regulatory strategy, submissions and meetings, clinical and PK design, CMC integration and vendor management, nonclinical strategy and studies, and commercial insights to maximize program potential from development through commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Regulatory Professionals company profile →
KBI Biopharma
HQ: United States
Website
- Description: Provider of fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally; a leading development and contract manufacturing organization serving the biopharmaceutical industry, working closely with client partners to personalize and rapidly accelerate drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full KBI Biopharma company profile →
Toxikon
HQ: United States
Website
- Description: Provider of preclinical contract research services delivering medical device product development from concept to final product, including biocompatibility testing, microbiology and reusability validation, analytical chemistry, efficacy and surgical services, and consulting and risk assessment for regulatory compliance and market approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Toxikon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ProBioGen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ProBioGen
2.2 - Growth funds investing in similar companies to ProBioGen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ProBioGen
4.2 - Public trading comparable groups for ProBioGen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →